Last reviewed · How we verify
Oral administration of vitamin B12
Oral administration of vitamin B12 is a Small molecule drug developed by University Hospital, Basel, Switzerland. It is currently FDA-approved. Also known as: Cyanocobolamin, B12 "Ankermann" 1 mg.
The oral administration of vitamin B12, developed by University Hospital, Basel, Switzerland, is a marketed product with a key composition patent expiring in 2028. A key strength of this formulation is its oral delivery method, which offers convenience and potentially improved patient compliance compared to injectable forms. The primary risk is the lack of revenue data and key trial results, which may limit its competitive positioning against established alternatives.
At a glance
| Generic name | Oral administration of vitamin B12 |
|---|---|
| Also known as | Cyanocobolamin, B12 "Ankermann" 1 mg |
| Sponsor | University Hospital, Basel, Switzerland |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Pembrolizumab Plus Bevacizumab and Chemotherapy for Non-Squamous NSCLC Patients (PHASE2)
- Patient Blood Management in Cardiac Surgery (NA)
- Microbiological and Clinical Effects of Pre- and Probiotics in Non-Surgical Periodontal Therapy (NA)
- Intrapleural Photodynamic Therapy in a Multimodal Treatment for Patients With Malignant Pleural Mesothelioma (PHASE2)
- A Study to See Whether Taking a Mix of Vitamins Can Help Adults Recover Better After Surgery for Carpal Tunnel Syndrome (NA)
- Nucleo CMP and Neurorubine Versus Carbamazepine for Classical Trigeminal Neuralgia (PHASE2)
- Oral Sucrosomial® Vitamin B12 in the Management of B12 Deficiency Among Metformin-Treated Type 2 Diabetes Patients (NA)
- Administration of Methionine in Patients With Pulmonary Alveolar Proteinosis by Mutation of the MARS Gene. (PHASE1, PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Oral administration of vitamin B12 CI brief — competitive landscape report
- Oral administration of vitamin B12 updates RSS · CI watch RSS
- University Hospital, Basel, Switzerland portfolio CI
Frequently asked questions about Oral administration of vitamin B12
What is Oral administration of vitamin B12?
Who makes Oral administration of vitamin B12?
Is Oral administration of vitamin B12 also known as anything else?
What development phase is Oral administration of vitamin B12 in?
Related
- Manufacturer: University Hospital, Basel, Switzerland — full pipeline
- Also known as: Cyanocobolamin, B12 "Ankermann" 1 mg
- Compare: Oral administration of vitamin B12 vs similar drugs
- Pricing: Oral administration of vitamin B12 cost, discount & access